Consultation Form [X]

Dr. Ashok Vaid


Dr. Ashok Vaid
Chairman Medical and Haemato Oncology, Cancer Institute

Consultation Form

Dr. Ashok Vaid

Dr. Ashok Vaid is the Chairman Medical and Haemato Oncology at Cancer Institute Medanta Hospital, Gurugram in India. He has been honoured with the prestigious Padma Shri Award. The Medical and Haemato Oncologist at Medanta Gurgaon has the unique distinction of carrying out the first 25 bone marrow transplants in any private sector hospital in North India. Dr. Vaid has also conducted over 40 international and national studies in clinical research and is known for organizing numerous seminars, workshops and conferences. Read Dr. Ashok Vaid Reviews to know about the Best Medical oncologist in India. Contact us to book Appointment Online with Medical Oncologist at Medanta Dr. Ashok Vaid via Email Address.

Medical Qualifications

  • MBBS - Jammu University, 1984
  • MD - Internal Medicine - Jammu University, 1989
  • Senior Resident - All India Institute of Medical Sciences, New Delhi, 1990
  • DM - Oncology - The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU), 1993

Specializations and Expertise

  • Organ-Specific Cancer Treatment
  • Solid Tumours
  • Leukemias
  • Lymphomas

Dr. Ashok Vaid’s Association with Medanta Hospital, Gurgaon

The Division of Medical Oncology and Haematology at Medanta Cancer Institute in Gurgaon offers specialised and multidisciplinary approach for the treatment of cancer. The line of treatment and techniques used includes the chemotherapy, biological therapy, hormone therapy, and targeted therapy. We provide a one-stop-solution for cancer diagnosis and treatment including evaluation, imaging, fiducial placement, treatment planning, recovery and prevention for complete cancer removal to help patients live life normally. We are dedicated to provide with the best-in-class yet affordable cancer care and services to our patients so that they lead a healthy life. Fill the consultation form to get an instant appointment with the Medical Oncologist in Gurugram.

The Department of Medical Oncology & Haematology has a lasting goal to deliver highest quality cancer care in a safe environment based on the latest advances in diagnostic and therapeutic research. We create a multifaceted department that promotes oncology education and cutting edge research in partnership with institutes of repute. To fix a quick appointment, get in touch with Dr. Ashok Vaid Contact Number given on our website.


Dr. Ashok Vaid, Chairman Medical and Haemato Oncology , Cancer Institute at Medanta Hospital, Gurgaon talks about cancer, the common types of cancer in India, the treatment modalities for cancer, importance of radiation, cancer care and cancer awareness.

dr ashok vaid video

Doctor Experience

  • Chairman - Division of Medical & Paediatric Oncology, Haematology & Bone Marrow / Stem Cell Transplant Medanta - The Medicity, Gurgaon, 2009 - till date
  • Head, Dept. of Medical Oncology, Artemis Health Institute, Gurgaon, India, 2007 – 2009
  • Sr. Consultant & Coordinator, Dept. of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India, 1997-2007
  • Consultant -Medical Oncologist & Lecturer Dept. of Internal Medicine Govt. Medical College, Jammu, J&K, India, 1994-1997
  • Post MD Training Towards Award of DM Degree, Medical Oncology, Cancer Institute, Adyar, Chennai, India, 1991-1993
  • Senior Resident, Dept. of Medical Oncology, All India Institute of Medical Science (AIIMS), New Delhi, India, 1990-1991
  • Senior Resident, Dept. of Clinical Immunology, SGPGI, Lucknow, UP, India Jan - Apr 1990
  • Senior Residency towards award of MD degree in Internal Medicine, Govt. Medical College, Jammu, Jammu & Kashmir, India 1987-1989

Memberships & Certifications

  • Member of Indian Society of Medical & Pediatric Oncology (ISMPO)
  • Life Member of Breast Cancer Foundation of India
  • Founder Member of Indian Cooperative Oncology Network (ICON)
  • Life Member of Indian Association of Gynaec Oncologists (IAGO)
  • Member of Association of Physicians of India (API)
  • Life Member of Indian Medical Association (IMA)
  • Member of American Society of Clinical Oncology (ASCO)
  • Member of European Society for Medical Oncology (ESMO)
  • Life Member of Indian Association of Clinical Medicine (IACM)
  • Member of Editorial Board of Current Trends in Asian Oncology
  • Member of European Hematology Association (EHA)
  • Consultant Editor at JK Science (Journal of Medical Education & Research)

Awards and Accomplishments

  • Padma Shri Award, 2009
  • Chikitsa Shiromani Award, 2007


  • Indian J Cancer: Management of Malignant Germ Cell Tumours of Ovary, 1992
  • Indian J Cancer: Synchronous oesophageal carcinoma with non Hodgkin's lymphoma, problems with management, 1996
  • Ind J Med & Ped Oncol: Prognostic factors in early stage Non-Small Lung Carcinoma, 1999
  • Fuels Published by Teri, Delhi. Pg 19-23: Environmental Pollution and Lung Cancer. In: Clearing the Air Better Vehicles, Better, 2000
  • IJCP’s Medinews: New Hormonal Treatments in Breast Cancer, 2000
  • Tropical Gastroenterol. Jul-Sep;22(3):170-1: Small cell carcinoma of the gall bladder: case report and review of literature, 2001
  • Medicine Update Vol.12,194:1337: GCP in India-Practice or Not, 2002
  • The Journal of Vascular Access. 4:158-159: Spontaneous fracture and pulmonary embolization of a central venous catheter, 2003
  • Indian J Dermatol Venerol Leprol 70:46-47: Flagellate hyperpigmentation from bleomycin, 2004
  • JIACM: Thymic Carcinoma Presenting as Myasthenia Gravis, 2004
  • Indian J Dermatol Venerol Leprol 70:46-47: Synchronous Cancer of Squamous Cell Carcinoma Lung (NSCLC) & Chronic Lymphocytic Leukemia, 2004
  • JIACM: Thalidomide, Physician’s Digest Disease Management, 2004
  • JK Science (Journal of Medical Education & Research) Vol.7 No.2, April-June 2005: p63-66: Hodgkin’s Disease: Risk Stratification and Multidisciplinary Treatment, 2005
  • Indian Journal of Medical & Paediatric Oncology (JMPO), Vol.26 No.1, March, 2005 (Review-II): Malignant Gastrointestinal Stromal Tumours (GISTs), 2005
  • Indian J Dermatol Venereol Leprol. 2005 May-Jun;71(3):208-9 : Gastric carcinoma presenting as cutaneous metastases, 2005
  • Hepatobiliary Pancreat Dis. Int. Vol.4,No.2, May 15,2005:308-10: Bone metastases from primary hepatocellular carcinoma simulating multiple myeloma, 2005
  • Delhi State Chapter : Emergency Medicine Association of Physicians of India, 2005
  • Indian Journal of Clinical Practice, July 2005, Vol.16, No.2: Nutritional Support in Hematopoietic Stem Cell Transplantation, 2005
  • The Oncology Knowledge Bank Lung Cancer, Vol.1, 2006. ISBN: 81-7525-703-2: Prognostic Factors in Lung Cancer, 2006
  • Colorectal Cancer (Awareness Month): Overview of Rectal Cancer, 2006
  • Haema 2006; 9(2):286-289: Primary Testicular Lymphoma: A Case Report, 2006
  • Hepatobiliary Pancreat Dis Int. 2006 May; 5(2):305-7. Review. PMID:16698597: Breast carcinoma with metastasis to the gallbladder: an unusual case report with a short review of literature, 2006
  • Hongkong Journal of Nephrology 2006;8(2) : Primary Renal Osteogenic Sarcoma: a rare entity, 2006
  • World Journal of Gastroenterology : Spinal Cord Compression Secondary to Bone Metastases from Hepatocellular Carcinoma, 2006
  • UICC World Cancer Congress, Medimond International Proceedings, Washington, D.C. (USA) : Significant Impact of a Single Gallium (Ga67) Scintigraphy in the Management of Lymphomas, 2006
  • JIMSA Oct-Dec.2006 Vol.19, no.4 (Case Report) : Bleomycin-Induced Flagellate hyperpigmentation, 2006
  • Indian Heart J 2007 Nov-Dec; 59(6):511-4 : Feasibility and safety of autologous intracoronary stem cell transplantation in patients of non ischemic dilated cardiomyopathy, 2007
  • Journal of Association of Physicians of India 2007 June; Vol55:451-452 : Isolated intraorbital metastasis in carcinoma breast, 2007
  • Indian association of clinical medicine. p343-348: Chapter 37. Jaypee Brothers Publication : Clinical medicine: A practical manual for students and practitioners, 2007
  • Sao Paulo Medical Journal 2007; 125(5):286-288. PMID: 18094896 : Primary Testicular Non-Hodgkin’s Lymphoma-A Review Article, 2007
  • placebo-controlled, phase-2 trial: C1-05, Journal of Thoracic Oncology, Volume 2 - Issue 8 - p S360 : Oral Talactoferrin extends survival in patients with refractory NSCLC in a randomized, 2007
  • Singapore Med J 2007; 48(3) : e77 : Pure choriocarcinoma of testis with rare gingival and skin metastases, 2007
  • Journal of Thoracic Oncology; Volume 2, Number 8 : Report of a case of pericardial mesothelioma with liver metastases responding well to pemetrexed and platinum-based chemotherapy, 2007
  • J Assoc Physicians India. 2008 Dec;56:1001-2 : Diagnostic dilemma: non-gestational or gestational choriocarcinoma of the ovary, 2008
  • Br J Radiol. 2008, Nov;81(971): 865-71 : Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer, 2008
  • J Clin Oncol. 2009 Nov 20;27(33):5529-37. Epub : Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study, 2009
  • The Indian Journal of Chest Diseases & Allied Sciences : Haematologic Paraneoplastic Syndromes in Pleural Mesothelioma: A Report of Two Cases and Review of the Literature, 2009
  • Case Rep Gastroenterol. 2009; 3(1): 21–25 : Metastatic Signet-Ring Cell Gastric Carcinoma Masquerading as Breast Primary, 2009
  • Indian Journal of Cancer Vol:48(4):438-445 : Nilotinib as first line therapy for Chronic Myeloid Leukemia, 2011
  • Indian Cancer Society, Delhi Branch, : Tobacco: Lung Cancer, Annual Seminar: Cancer Sahyog, 2011
  • Cancer Sahyog A unit of Indian Cancer Society, Delhi Branch : Importance of Screening in Various Cancers. Annual Seminar, 2011
  • J Clin Oncol. 2011 Nov 1;29(31): 4129-36. Epub : Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy, 2011
  • Indian J Cancer. 2011 Apr-Jun;48(2):158-64 : Management of primary and metastatic triple negative breast cancer: perceptions of oncologists from India, 2011
Back to Top